Skip to content

Role of Curcumin and Spirulina in restricted mouth opening.

Comparative study of efficacy of Curcumin and Spirulina in the management of oral submucous fibrosis. A randomised controlled trial. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/059790
Enrollment
58
Registered
2023-11-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K135- Oral submucous fibrosis

Interventions

Intervention1: Spirulina: Spirulina is a type of blue-green algae having antioxidant, anti-inflammatory and immunomodulatory effects. It contains various antioxidants, such as phycocyanin and beta-car

Sponsors

Dr. Sanika Vaje
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with history of areca nut chewing or any other tobacco related product. 2. Clinically diagnosed as OSMF(stage I and stage II) according to Nagesh and Bailoor. 3. Patients who are willing to participate in the study. 4. No history of prior treatment for the same.

Exclusion criteria

Exclusion criteria: 1. Patients who did not give consent for participation. 2. Patients suffering from hypertension, diabetes or any cardiac, respiratory, renal, and hepatic disease. 3. Pregnant women and lactating mothers. 4. History of hypersensitivity to turmeric, spirulina or other antioxidants.

Design outcomes

Primary

MeasureTime frame
1. Burning Sensation 2. Mouth openingTimepoint: 1. Burning Sensation and pain- will be recorded by VAS score after every 15 days for 3 months. 2. Mouth opening- will be recorded by geometric scale after every 15 days for 3 months.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Manjushri Waingade

Sinhgad Dental College and Hospital, Pune

manju.waingade@gmail.com7875044983

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026